Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 3/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 2/20 | 0.30 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30952976 | 0.93 | IL17A (0.36) | IL17AMMP13CDK2CCNE1GSK3B | |
| SCHEMBL30953099 | 0.85 | IL17A (0.44) | IL17AMMP13 | |
| SCHEMBL30953528 | 0.85 | AAK1 (0.39) | IL17A | |
| SCHEMBL30953104 | 0.85 | IL17A (0.38) | IL17AMMP13 | |
| SCHEMBL30952938 | 0.85 | IL17A (0.45) | IL17ACDK2CCNE1GSK3BF11 | |
| SCHEMBL30953015 | 0.84 | IL17A (0.35) | IL17ACDK2CCNE1GSK3B | |
| SCHEMBL30953095 | 0.83 | IL17A (0.34) | IL17ACDK2CCNE1 | |
| SCHEMBL30953020 | 0.83 | CDK2 (0.32) | IL17ACDK2CCNE1GSK3B | |
| Hydrochloric Acid SCHEMBL30953298 | 0.83 | NR3C2 (0.35) | IL17A | |
| SCHEMBL30953101 | 0.83 | CDK2 (0.33) | IL17ACDK2CCNE1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |